SSY Group Limited (2005.HK)

HKD 3.06

(0.66%)

Operating Income Summary of SSY Group Limited

  • SSY Group Limited's latest annual operating income in 2023 was 1.63 Billion HKD , up 11.99% from previous year.
  • SSY Group Limited's latest quarterly operating income in 2024 Q2 was 849.28 Million HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported an annual operating income of 1.35 Billion HKD in 2022, up 50.31% from previous year.
  • SSY Group Limited reported an annual operating income of 903.79 Million HKD in 2021, up 31.53% from previous year.
  • SSY Group Limited reported a quarterly operating income of 747.18 Million HKD for 2023 Q2, down 0.0% from previous quarter.
  • SSY Group Limited reported a quarterly operating income of 742.95 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of SSY Group Limited (2023 - 2004)

Historical Annual Operating Income of SSY Group Limited (2023 - 2004)

Year Operating Income Operating Income Growth
2023 1.63 Billion HKD 11.99%
2022 1.35 Billion HKD 50.31%
2021 903.79 Million HKD 31.53%
2020 687.16 Million HKD -44.7%
2019 1.24 Billion HKD 12.08%
2018 1.1 Billion HKD 29.98%
2017 852.99 Million HKD 27.96%
2016 666.59 Million HKD 23.34%
2015 540.45 Million HKD -12.47%
2014 617.44 Million HKD 14.59%
2013 538.83 Million HKD 44.76%
2012 372.21 Million HKD 2731.4%
2011 13.14 Million HKD -95.95%
2010 324.99 Million HKD 15.75%
2009 280.78 Million HKD 112.06%
2008 132.4 Million HKD -20.78%
2007 167.12 Million HKD 72.24%
2006 97.03 Million HKD -27.2%
2005 133.28 Million HKD 2.52%
2004 130 Million HKD 0.0%

Peer Operating Income Comparison of SSY Group Limited

Name Operating Income Operating Income Difference
Pak Fah Yeow International Limited 143.01 Million HKD -1045.988%
Grand Pharmaceutical Group Limited 2.66 Billion HKD 38.466%
Extrawell Pharmaceutical Holdings Limited -8.16 Million HKD 20179.65%
Wai Yuen Tong Medicine Holdings Limited 40.88 Million HKD -3909.053%
Qianhai Health Holdings Limited -52.18 Million HKD 3240.68%
Lee's Pharmaceutical Holdings Limited 36.04 Million HKD -4447.198%
Essex Bio-Technology Limited 310.32 Million HKD -428.116%
Tongfang Kontafarma Holdings Limited - HKD -Infinity%
PuraPharm Corporation Limited -66.04 Million HKD 2581.454%
JBM (Healthcare) Limited 174.2 Million HKD -840.789%
Jacobson Pharma Corporation Limited 333.12 Million HKD -391.976%
China Resources Pharmaceutical Group Limited 12.14 Billion HKD 86.508%